Clinical Trials

TOMORROW'S MEDICINE TODAYSpectrum Research Institute Clinical Trials

20 Years of PI Excellence

Benefit from decades of specialized expertise in hepatology and gastroenterology.

White-Glove Patient Care

Our concierge model includes a travel concierge, real-time reimbursements, and personalized patient coordination to ensure a “High-Tech Healing” environment.

Non-Invasive Diagnostics

Experience the “Frictionless Path to Liver Health” with advanced, biopsy-free screening tools in our 6,500 sqft Phoenix facility.

Paid Clinical Trials in Phoenix

We offer compensated research opportunities for obesity, weight loss, MASH, and IBD, providing no-cost care and access to tomorrow’s therapies.

HEPATOLOGY TREATMENTSLeading the Way in MASH and Liver Health Research

At Spectrum Research Institute, we are at the forefront of the global shift in hepatology, serving as a "Center of Excellence" for the latest diagnostic and therapeutic guidelines.

As the medical community transitions from the legacy term Nonalcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-Associated Steatohepatitis (MASH), our Phoenix-based facility offers patients access to the next generation of liver care. Leveraging over 20 years of Principal Investigator experience, we prioritize a “Biomarker-First” approach, utilizing advanced, non-invasive tools like VCTE (FibroScan) and MRE to assess liver health without the need for traditional, invasive biopsies. Our trials focus on resolving liver fibrosis and improving metabolic health for adults managing conditions like Type 2 Diabetes and obesity.

Schedule a Fibroscan

IMMUNO-GASTROENTEROLOGYAdvancing Care for Inflammatory Bowel Disease (UC & Crohn’s)

For patients living with Ulcerative Colitis or Crohn’s Disease, especially those who have not found relief through standard treatments or have experienced "biologic failure," our clinical trials provide a critical new path forward.

We treat our state-of-the-art 6,500 square foot facility in metropolitan Phoenix as a “Stable Haven,” offering a “White Glove” concierge experience that prioritizes patient dignity and comfort. By participating in our IBD research, patients gain Access to Tomorrow’s Medicine Today, working with a dedicated team to explore novel therapies designed to induce and maintain long-term remission. Our specialized diagnostic tools ensure that every participant receives high-fidelity monitoring and personalized care throughout their journey.

PRECISION ONCOLOGYInnovation in Cancer Biomarkers and Precision Medicine

Our commitment to Biomarker Innovation extends to the cutting edge of oncology, where we facilitate trials that harness the power of precision medicine.

Cancer biomarkers—biological indicators found in blood, tissue, or fluids—are essential tools for early detection and for predicting how a patient will respond to specific targeted therapies. By identifying unique genetic mutations or protein signatures, these clinical trials allow for a more personalized approach to treatment, moving away from a “one-size-fits-all” model. As a site defined by scientific rigor and high-fidelity diagnostics, we provide a vital link between revolutionary biomarker research and the patients who stand to benefit most from these life-saving innovations.